中国P站

Gene Expression; Single-cell RNA Sequencing; Spatial Transcriptomics; CRISPR-Cas; Epigenetics; Long Non-coding RNAs; Multi-omics; Machine Learning; Exosomal RNAs; Cancer Immunotherapy

Introduction

This review highlights the rapid evolution of single-cell RNA sequencing (scRNA-seq) over the past decade, discussing its transformative impact on understanding cell heterogeneity and gene expression at an individual cell level. It covers methodological advancements, computational tools, and addresses existing challenges while looking towards future directions in the field[1].

This article explores how spatial transcriptomics technologies are revolutionizing our understanding of tissue organization and cell-cell communication by enabling gene expression analysis while preserving the spatial context of cells within tissues. It covers the principles, applications, and challenges of various spatial transcriptomics approaches, highlighting their potential in disease research and therapy development[2].

This article surveys the expanding utility of CRISPR-Cas systems, presenting them as a versatile toolbox for various applications in gene editing, regulation, and functional genomics. It discusses advancements in directing gene expression, modifying epigenetic marks, and screening for genetic interactions, underscoring their power in unraveling complex biological pathways[3].

This review elucidates the critical and diverse roles of long non-coding RNAs (lncRNAs) in the pathogenesis of various human diseases. It outlines their mechanisms of action in regulating gene expression, including epigenetic, transcriptional, and post-transcriptional control, and discusses their growing potential as diagnostic biomarkers and therapeutic targets[4].

This paper delves into the intricate world of epigenetic modifications, such as DNA methylation and histone modifications, and their profound impact on gene regulation. It highlights how these reversible chemical changes, without altering the DNA sequence, control gene expression, influencing cellular differentiation, development, and disease progression[5].

This review focuses on the rapid advancements in single-cell multi-omics technologies, which enable simultaneous profiling of multiple molecular layers, like genomics, transcriptomics, and epigenomics, within individual cells. It discusses how these integrated approaches are crucial for dissecting cellular heterogeneity and understanding complex biological processes with unprecedented resolution[6].

This comprehensive review examines the growing application of machine learning techniques in gene expression analysis, detailing how algorithms are employed for tasks suchs as identifying biomarkers, predicting disease outcomes, and uncovering regulatory networks. It emphasizes the transformative potential of Artificial Intelligence (AI) to extract meaningful insights from large-scale genomics data[7].

This article explores the growing understanding of circulating exosomal RNAs and their significant potential as non-invasive biomarkers for early disease detection, prognosis, and therapeutic monitoring. It highlights how these RNAs, encapsulated within exosomes, reflect gene expression changes in their parent cells and contribute to intercellular communication[8].

This review delves into the crucial role of gene expression profiling in advancing cancer immunotherapy, particularly in identifying predictive biomarkers for patient response and understanding mechanisms of resistance. It explores how high-throughput gene expression analyses guide personalized treatment strategies and improve therapeutic outcomes[9].

This review examines the advancements and growing applications of long-read sequencing technologies in biomedicine, particularly in gene expression analysis. It highlights how these methods, by spanning entire transcripts, overcome limitations of short-read sequencing to reveal complex isoforms, fusion genes, and accurate quantification of gene expression, enhancing our understanding of disease mechanisms[10].

Description

The rapidly evolving landscape of molecular biology is continually revealing intricate details of gene expression and cellular regulation, profoundly impacting our understanding of health and disease.

This review highlights the rapid evolution of single-cell RNA sequencing (scRNA-seq) over the past decade, discussing its transformative impact on understanding cell heterogeneity and gene expression at an individual cell level. It covers methodological advancements, computational tools, and addresses existing challenges while looking towards future directions in the field [1]. This article explores how spatial transcriptomics technologies are revolutionizing our understanding of tissue organization and cell-cell communication by enabling gene expression analysis while preserving the spatial context of cells within tissues. It covers the principles, applications, and challenges of various spatial transcriptomics approaches, highlighting their potential in disease research and therapy development [2]. This review focuses on the rapid advancements in single-cell multi-omics technologies, which enable simultaneous profiling of multiple molecular layers, like genomics, transcriptomics, and epigenomics, within individual cells. It discusses how these integrated approaches are crucial for dissecting cellular heterogeneity and understanding complex biological processes with unprecedented resolution [6].

This article surveys the expanding utility of CRISPR-Cas systems, presenting them as a versatile toolbox for various applications in gene editing, regulation, and functional genomics. It discusses advancements in directing gene expression, modifying epigenetic marks, and screening for genetic interactions, underscoring their power in unraveling complex biological pathways [3]. This review elucidates the critical and diverse roles of long non-coding RNAs (lncRNAs) in the pathogenesis of various human diseases. It outlines their mechanisms of action in regulating gene expression, including epigenetic, transcriptional, and post-transcriptional control, and discusses their growing potential as diagnostic biomarkers and therapeutic targets [4]. This paper delves into the intricate world of epigenetic modifications, such as DNA methylation and histone modifications, and their profound impact on gene regulation. It highlights how these reversible chemical changes, without altering the DNA sequence, control gene expression, influencing cellular differentiation, development, and disease progression [5].

This comprehensive review examines the growing application of machine learning techniques in gene expression analysis, detailing how algorithms are employed for tasks suchs as identifying biomarkers, predicting disease outcomes, and uncovering regulatory networks. It emphasizes the transformative potential of Artificial Intelligence (AI) to extract meaningful insights from large-scale genomics data [7]. This review examines the advancements and growing applications of long-read sequencing technologies in biomedicine, particularly in gene expression analysis. It highlights how these methods, by spanning entire transcripts, overcome limitations of short-read sequencing to reveal complex isoforms, fusion genes, and accurate quantification of gene expression, enhancing our understanding of disease mechanisms [10].

This article explores the growing understanding of circulating exosomal RNAs and their significant potential as non-invasive biomarkers for early disease detection, prognosis, and therapeutic monitoring. It highlights how these RNAs, encapsulated within exosomes, reflect gene expression changes in their parent cells and contribute to intercellular communication [8]. This review delves into the crucial role of gene expression profiling in advancing cancer immunotherapy, particularly in identifying predictive biomarkers for patient response and understanding mechanisms of resistance. It explores how high-throughput gene expression analyses guide personalized treatment strategies and improve therapeutic outcomes [9].

Conclusion

Recent advancements have significantly deepened our understanding of gene expression and cellular biology. Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of cell heterogeneity, offering insights into gene expression at an individual cell level and paving the way for future developments [1]. Alongside this, spatial transcriptomics has emerged as a powerful tool, preserving the spatial context of cells during gene expression analysis, which is vital for understanding tissue organization and intercellular communication in disease research [2]. Beyond observational techniques, CRISPR-Cas systems provide a versatile platform for gene editing, regulation, and functional genomics, demonstrating immense potential in dissecting intricate biological pathways [3]. The regulatory landscape of gene expression is also being redefined by long non-coding RNAs (lncRNAs), which are increasingly recognized for their diverse roles in human diseases and their promise as diagnostic and therapeutic targets [4]. Furthermore, epigenetic modifications, including DNA methylation and histone modifications, are central to gene regulation, controlling gene expression without altering the underlying DNA sequence and impacting cellular differentiation and disease progression [5]. Integrated approaches are pushing the boundaries of biological inquiry. Single-cell multi-omics technologies enable the simultaneous profiling of various molecular layers within individual cells, offering unparalleled resolution for understanding cellular heterogeneity [6]. The sheer volume of data generated by these technologies necessitates sophisticated analytical tools; here, machine learning algorithms are proving invaluable in gene expression analysis for identifying biomarkers, predicting disease outcomes, and uncovering complex regulatory networks [7]. The clinical relevance of these molecular insights is also expanding. Circulating exosomal RNAs are gaining recognition as promising non-invasive biomarkers, reflecting gene expression changes and facilitating intercellular communication relevant to disease detection and monitoring [8]. In cancer treatment, gene expression profiling is instrumental in advancing immunotherapy, helping identify predictive biomarkers and resistance mechanisms to guide personalized strategies [9]. Lastly, long-read sequencing technologies are enhancing gene expression analysis by accurately quantifying expression and uncovering complex isoforms, overcoming previous limitations and refining our comprehension of disease mechanisms [10].

References

1. Timothy S, Andrew B, Paul H (2019) Annu Rev Cell Dev Biol 35 285-304.

   , ,

2. Xiang C, Xu L, Chao G (2023) J Med Genet 60 541-549.

   , ,

3. Ming D, Bin Z, Yi C (2023) Front Cell Dev Biol 11 1157975.

   , ,

4. Shuya M, Yuan L, Shang Z (2020) Signal Transduct Target Ther 5 161.

   , ,

5. Hadjara M, Congmei S, Rui S (2023) Front Cell Dev Biol 11 1205307.

   , ,

6. Shan Y, Jie H, Yu L (2023) Comput Struct Biotechnol J 21 5310-5321.

   , ,

7. Zhonghua L, Shuyue W, Yan L (2021) Front Genet 12 757820.

   , ,

8. Peipei W, Juan S, Yan Q (2020) J Exp Clin Cancer Res 39 236.

   , ,

9. Xiaoyan C, Jun L, Wei M (2023) Front Immunol 14 1198595.

   , ,

10. Hao Z, Shi L, Qi L (2023) Int J Mol Sci 24 11508.

    , ,